vs
Side-by-side financial comparison of CIVISTA BANCSHARES, INC. (CIVB) and MEDIFAST INC (MED). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $47.3M, roughly 1.6× CIVISTA BANCSHARES, INC.). Over the past eight quarters, CIVISTA BANCSHARES, INC.'s revenue compounded faster (11.3% CAGR vs -34.4%).
Civista Bancshares, Inc. is a US-based bank holding company operating primarily across the Midwest region. It provides a full suite of personal and commercial banking services including deposit accounts, mortgage, consumer and commercial lending products, as well as wealth management solutions, serving retail consumers, small and medium-sized local businesses and community client segments.
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
CIVB vs MED — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.3M | $75.1M |
| Net Profit | $15.0M | — |
| Gross Margin | — | 69.4% |
| Operating Margin | — | -10.4% |
| Net Margin | 31.7% | — |
| Revenue YoY | — | -36.9% |
| Net Profit YoY | 47.4% | — |
| EPS (diluted) | $0.72 | $-1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $47.3M | — | ||
| Q4 25 | $46.3M | $75.1M | ||
| Q3 25 | $44.2M | $89.4M | ||
| Q2 25 | $41.4M | $105.6M | ||
| Q1 25 | $40.6M | $115.7M | ||
| Q4 24 | $40.4M | $119.0M | ||
| Q3 24 | $39.3M | $140.2M | ||
| Q2 24 | $38.1M | $168.6M |
| Q1 26 | $15.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $12.8M | $-2.3M | ||
| Q2 25 | $11.0M | $2.5M | ||
| Q1 25 | $10.2M | $-772.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $8.4M | $1.1M | ||
| Q2 24 | $7.1M | $-8.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 69.4% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 72.6% | ||
| Q1 25 | — | 72.8% | ||
| Q4 24 | — | 74.1% | ||
| Q3 24 | — | 75.4% | ||
| Q2 24 | — | 73.2% |
| Q1 26 | — | — | ||
| Q4 25 | 31.8% | -10.4% | ||
| Q3 25 | 35.4% | -4.6% | ||
| Q2 25 | 31.1% | -1.0% | ||
| Q1 25 | 29.4% | -1.1% | ||
| Q4 24 | 28.2% | 0.6% | ||
| Q3 24 | 25.2% | 1.5% | ||
| Q2 24 | 21.2% | -4.7% |
| Q1 26 | 31.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 28.9% | -2.5% | ||
| Q2 25 | 26.6% | 2.3% | ||
| Q1 25 | 25.0% | -0.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | 21.3% | 0.8% | ||
| Q2 24 | 18.5% | -4.8% |
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.59 | $-1.64 | ||
| Q3 25 | $0.68 | $-0.21 | ||
| Q2 25 | $0.71 | $0.22 | ||
| Q1 25 | $0.66 | $-0.07 | ||
| Q4 24 | $0.62 | $0.08 | ||
| Q3 24 | $0.53 | $0.10 | ||
| Q2 24 | $0.45 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $553.9M | $198.9M |
| Total Assets | $4.3B | $248.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $167.3M | ||
| Q3 25 | — | $173.5M | ||
| Q2 25 | — | $162.7M | ||
| Q1 25 | — | $164.6M | ||
| Q4 24 | — | $162.3M | ||
| Q3 24 | — | $170.0M | ||
| Q2 24 | — | $163.5M |
| Q1 26 | $553.9M | — | ||
| Q4 25 | $543.5M | $198.9M | ||
| Q3 25 | $499.0M | $214.7M | ||
| Q2 25 | $404.1M | $216.0M | ||
| Q1 25 | $397.4M | $211.0M | ||
| Q4 24 | $388.5M | $210.1M | ||
| Q3 24 | $394.4M | $207.3M | ||
| Q2 24 | $373.8M | $205.3M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $248.0M | ||
| Q3 25 | $4.1B | $268.2M | ||
| Q2 25 | $4.2B | $269.3M | ||
| Q1 25 | $4.1B | $280.0M | ||
| Q4 24 | $4.1B | $284.2M | ||
| Q3 24 | $4.1B | $291.2M | ||
| Q2 24 | $4.0B | $293.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-5.3M |
| Free Cash FlowOCF − Capex | — | $-6.6M |
| FCF MarginFCF / Revenue | — | -8.8% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $43.3M | $-5.3M | ||
| Q3 25 | $19.0M | $12.1M | ||
| Q2 25 | $11.1M | $-3.4M | ||
| Q1 25 | $3.6M | $3.4M | ||
| Q4 24 | $48.2M | $-4.9M | ||
| Q3 24 | $12.9M | $9.1M | ||
| Q2 24 | $12.2M | $13.1M |
| Q1 26 | — | — | ||
| Q4 25 | $42.1M | $-6.6M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $-4.8M | ||
| Q1 25 | $3.5M | $1.9M | ||
| Q4 24 | $44.1M | $-7.2M | ||
| Q3 24 | — | $7.7M | ||
| Q2 24 | — | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | 90.9% | -8.8% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | -4.5% | ||
| Q1 25 | 8.5% | 1.6% | ||
| Q4 24 | 109.1% | -6.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 2.5% | 1.8% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | 0.4% | 1.3% | ||
| Q4 24 | 10.4% | 1.9% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.49× | — | ||
| Q2 25 | 1.01× | -1.36× | ||
| Q1 25 | 0.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.54× | 8.04× | ||
| Q2 24 | 1.73× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CIVB
| Net Interest Income | $37.8M | 80% |
| Noninterest Income | $9.4M | 20% |
MED
Segment breakdown not available.
